What is the appropriate next step in managing a patient with uncontrolled hypertension on losartan 50 mg daily, with home blood pressure frequently above 130/110 mm Hg, nighttime elevations, and white‑coat spikes?

Uncontrolled Hypertension Management

You should intensify antihypertensive therapy by either increasing losartan to 100 mg daily or adding a calcium channel blocker (CCB) or thiazide/thiazide-like diuretic to the current losartan 50 mg regimen. The home blood pressure readings of 130-140/110 mmHg represent true uncontrolled hypertension requiring immediate medication adjustment, while the elevated office readings likely reflect a white-coat effect superimposed on genuine hypertension.

Confirming True Hypertension vs White-Coat Effect

The clinical picture suggests both true uncontrolled hypertension AND a white-coat component:

• Home BP readings consistently above 135/85 mmHg threshold (with readings of 130-140 systolic and diastolic around 110 mmHg) confirm genuine uncontrolled hypertension 1
• The diastolic pressure of 110 mmHg is particularly concerning and well above the home BP threshold of 85 mmHg 1, 2
• Office readings "above 140" with patient nervousness suggest an additional white-coat effect, but this does NOT negate the need for treatment intensification given the elevated home readings 1

Ambulatory BP monitoring (ABPM) would be ideal here to definitively characterize the nighttime elevations and quantify the white-coat component, but is not required before intensifying therapy given the clearly elevated home readings 1. The 2018 Hypertension Canada guidelines specifically recommend ABPM or home BP monitoring for patients with "BP that is not below target despite receiving appropriate chronic antihypertensive therapy" 1.

Treatment Intensification Strategy

Following the 2020 ISH guidelines' stepwise approach for non-Black patients 3:

Step 1 (Current): Low-dose ARB (losartan 50 mg) ✓
Step 2 (Next): Either:

• Option A: Increase losartan to full dose (100 mg daily) 3, 4
• Option B: Add a DHP-CCB (e.g., amlodipine 5 mg) 3
• Option C: Add a thiazide/thiazide-like diuretic (hydrochlorothiazide 12.5 mg) 3

Recommended Approach

I recommend adding hydrochlorothiazide 12.5 mg to losartan 50 mg (or using a fixed-dose combination) based on:

1. Strong evidence for losartan/HCTZ combination efficacy: Multiple studies demonstrate robust BP reduction with losartan 50 mg/HCTZ 12.5 mg, with particular effectiveness for nighttime BP control 5, 6, 7

2. Nighttime BP elevation specifically addressed: The fixed-dose combination of losartan/HCTZ showed remarkable nocturnal antihypertensive potency, reducing nighttime SBP from 138±18 to 125±14 mmHg 6

3. Sustained long-term efficacy: 24-hour BP decreased from 137/89 to 123/81 mmHg and was maintained through 12 months, with home BP reductions from 153/85 to 132/75 mmHg 5, 7

4. Safety profile: Three-year safety data in Japanese patients showed minimal metabolic complications and markedly decreased adverse events after 1 year 8

5. FDA-approved dosing: The losartan label specifically recommends adding HCTZ 12.5 mg and/or increasing losartan to 100 mg based on BP response 4

Target Blood Pressure

Target BP < 130/80 mmHg based on 2020 ISH guidelines 3, with the goal of achieving control within 3 months 3. The current diastolic pressure of 110 mmHg is particularly concerning and requires aggressive management.

Monitoring Plan

• Reassess in 4 weeks with home BP monitoring (duplicate measures, morning and evening, for 7 days, discarding first day) 1
• If BP remains uncontrolled after reaching losartan 100 mg + HCTZ 12.5 mg, Step 3 would be increasing HCTZ to 25 mg 3
• If still uncontrolled, Step 4 would add spironolactone or alternative agents 3

Critical Caveats

Check medication adherence first 3 - this is often overlooked but essential before intensification. The 2020 ISH guidelines explicitly recommend checking adherence in the diagnostic workup 3.

Ensure proper home BP technique: Verify the patient is using a validated device and measuring correctly (seated, arm supported, appropriate cuff size, 5 minutes rest) 1, 2. The 2018 Hypertension Canada guidelines emphasize that healthcare professionals should observe patients measuring BP to ensure correct technique 1.

Consider secondary hypertension evaluation if BP remains resistant after triple therapy, though the one-year duration and lack of other concerning features make this less urgent 1.

The white-coat component does not justify withholding treatment - the home readings alone mandate intensification 1, 9. The 2025 AHA/ACC guidelines clarify that white-coat effect (elevated office BP in treated patients with controlled home BP) should not trigger intensification, but this patient has uncontrolled home BP requiring action 9.